Uplift Plus – Strong Full-Spectrum Vijaya Extract | For Chronic Pain, De-Addiction and Insomnia

Cannazo India Uplift Plus – Extra-Strength Full-Spectrum Tincture

Cannazo India Uplift Plus is an extra-strength, THC-dominant full-spectrum Vijaya (Cannabis sativa) tincture formulated for experienced adult users under the supervision of a qualified medical practitioner.

The formulation contains 3860 mg total cannabinoids and combines a THC-dominant Vijaya leaf extract with Super Lemon Haze and OG Kush plant-derived cannabis terpenes (CDT). Designed for sublingual administration, the tincture provides a concentrated cannabinoid format intended for carefully controlled dosing.

Cannabinoids interact with the body’s Endocannabinoid System (ECS), a biological signalling network involved in pain perception, mood, appetite, sleep, stress response, and neurological processes. THC, the dominant cannabinoid in this formulation, primarily interacts with CB1 receptors in the central nervous system and can produce significant psychoactive effects.

Because of its high cannabinoid concentration and psychoactive nature, Uplift Plus is not intended for cannabis beginners. It should be used only according to the advice of a qualified medical practitioner.

The formulation is particularly suited to individuals who require a concentrated cannabinoid preparation and are already familiar with THC-containing products under appropriate professional supervision.

What Makes Uplift Plus Different?

Extra-Strength Full-Spectrum Cannabinoid Formulation

Uplift Plus uses a full-spectrum Vijaya extract rather than an isolated single cannabinoid.

A full-spectrum cannabis extract can contain multiple naturally occurring phytocannabinoids and plant compounds, including:

• THC
• CBD
• Minor cannabinoids
• Terpenes
• Flavonoids
• Other naturally occurring phytochemicals

The combination of these compounds contributes to the overall pharmacological and sensory profile of the extract.

The formulation is standardized to 3860 mg total cannabinoids, making it a concentrated preparation that requires careful dose titration.

THC-Dominant Cannabinoid Profile

THC, or delta-9-tetrahydrocannabinol, is the principal psychoactive phytocannabinoid in cannabis.

THC acts primarily as a partial agonist at CB1 cannabinoid receptors. CB1 receptors are widely distributed throughout the brain and central nervous system and participate in the regulation of:

• Pain perception
• Motor coordination
• Memory
• Appetite
• Mood
• Reward processing
• Stress responses
• Sensory perception

Because CB1 receptors are concentrated in neurological tissues, THC can produce psychoactive effects including altered perception, relaxation, euphoria, sedation, impaired coordination, or changes in concentration.

The intensity of these effects depends on dose, tolerance, metabolism, previous cannabinoid exposure, and individual physiology.

Super Lemon Haze & OG Kush Cannabis-Derived Terpenes

Uplift Plus is infused with Super Lemon Haze and OG Kush cannabis-derived terpenes (CDT).

Terpenes are naturally occurring aromatic compounds found throughout the plant kingdom. Within cannabis, they contribute substantially to the aroma, flavour, and sensory character of different cultivars.

The terpene profile of a cannabis formulation may influence its overall sensory experience and may interact with cannabinoid signalling.

The Uplift Plus terpene profile provides a combination of citrus, herbal, earthy, and botanical aromatic characteristics associated with these cannabis varieties.

Understanding the Endocannabinoid System

The Endocannabinoid System (ECS) is a biological signalling network that contributes to physiological homeostasis.

Its major components include:

• Endogenous cannabinoids
• Cannabinoid receptors
• Enzymes responsible for cannabinoid synthesis and degradation

The two primary cannabinoid receptors are CB1 and CB2.

CB1 Receptors

CB1 receptors are concentrated in the central nervous system.

Their activation influences:

• Nociception
• Neurotransmitter release
• Appetite
• Memory
• Motor control
• Mood
• Reward processing

THC’s interaction with CB1 receptors is responsible for much of its psychoactive activity.

CB2 Receptors

CB2 receptors are found predominantly in immune and peripheral tissues.

They participate in immune signalling and inflammatory processes.

The interaction between phytocannabinoids and these receptor systems forms the basis for ongoing research into medical cannabinoid applications.

Full-Spectrum Cannabinoid Synergy

A full-spectrum extract contains multiple plant compounds rather than a purified single cannabinoid.

The concept commonly referred to as the entourage effect proposes that cannabinoids and terpenes may influence one another’s biological effects.

Although this concept remains an active area of scientific investigation, preserving the plant’s broader phytochemical profile can produce a different pharmacological and sensory experience from an isolated THC or CBD preparation.

Uplift Plus therefore focuses on a whole-extract cannabinoid profile rather than a single isolated molecule.

Key Physiological Areas of Interest

Cannabinoid Support for Pain Modulation

Pain is a complex physiological process involving peripheral nerves, the spinal cord, and higher brain regions.

The ECS participates in nociceptive signalling, and cannabinoid receptors are present throughout pain-processing pathways.

THC can influence pain perception through CB1-mediated modulation of neurological signalling.

Cannabinoid preparations have been investigated in several forms of persistent pain, including:

• Neuropathic pain
• Musculoskeletal pain
• Arthritis-associated discomfort
• Chronic pain conditions

However, individual responses vary considerably.

Uplift Plus should not be presented as a cure for the underlying cause of chronic pain and should be used under professional medical guidance.

Stress and Relaxation Support

The ECS is involved in physiological responses to stress.

THC may produce subjective relaxation in some individuals, particularly at carefully controlled doses.

However, THC has a biphasic dose-response profile. Lower exposures may feel relaxing to some people, while higher exposures can produce anxiety, restlessness, impaired concentration, or psychological discomfort.

For this reason, dose titration is particularly important with a concentrated THC formulation such as Uplift Plus.

Mood and Emotional State

CB1 receptors are involved in several neurological pathways associated with reward, motivation, emotional processing, and sensory perception.

THC can influence these pathways and may produce subjective changes in:

• Mood
• Relaxation
• Perceived wellbeing
• Motivation
• Sensory experience

Responses are highly individual.

Uplift Plus should not be considered a treatment for clinical depression, anxiety disorders, or other psychiatric conditions unless specifically prescribed and supervised by an appropriately qualified healthcare professional.

Sleep and Night-Time Use

Cannabinoids interact with neurological pathways involved in the sleep-wake cycle.

THC can influence sleep architecture and may alter sleep latency and perceived sleep duration in some individuals.

The effects may depend heavily on dose and frequency of use.

While some individuals experience increased relaxation or sleepiness following THC exposure, prolonged or frequent cannabis use may also alter normal sleep architecture.

Uplift Plus should therefore not be used as a substitute for professional evaluation of persistent insomnia.

Appetite and Nutritional Support

The ECS has an important role in regulating appetite and food intake.

CB1 receptor signalling can influence hypothalamic and reward-related pathways involved in appetite.

THC may increase appetite in certain individuals.

Cannabinoid-based appetite support has been clinically investigated in specific medical contexts, but any therapeutic use for appetite loss should occur under medical supervision.

Cannabinoids and Substance-Use Recovery

Cannabinoids interact with neurological pathways involved in reward and reinforcement.

This has generated scientific interest in the potential role of cannabinoids in substance-use research.

However, THC itself is psychoactive and can be habit-forming for some individuals.

Therefore, Uplift Plus should not be marketed as a de-addiction treatment or as a proven method for stopping alcohol, nicotine, or other substance use.

Individuals undergoing addiction treatment should discuss cannabinoid use with their addiction specialist or physician rather than attempting to substitute THC for an established treatment plan.

Neurobiological Research

The ECS plays a significant role in neurological signalling.

Cannabinoid receptors are distributed throughout regions involved in:

• Movement
• Memory
• Coordination
• Sensory processing
• Neurotransmitter regulation

Cannabinoid research continues to investigate potential applications across neurological conditions.

However, evidence varies substantially between conditions, and Uplift Plus should not be represented as a treatment for Parkinson’s disease, dementia, epilepsy, or other neurological disorders without specific medical direction.

Sublingual Administration

Uplift Plus is designed for sublingual administration, meaning the measured quantity is placed beneath the tongue.

Sublingual delivery can facilitate absorption through the oral mucosa and may reduce dependence on gastrointestinal digestion compared with swallowing the product immediately.

Potential advantages include:

• Convenient administration
• Controlled dose titration
• Faster onset than conventional swallowed preparations
• Reduced first-pass metabolism for the fraction absorbed through oral tissues

The actual onset varies between individuals.

Pharmacokinetic Profile

Onset

Approximately:

30–60 minutes

when administered sublingually.

Duration

Approximately:

4–8 hours

depending on metabolism, tolerance, dose, food intake, and individual sensitivity.

The psychoactive effects may persist for longer in some individuals.

Composition

Component	Specification
Active Ingredient	Vijaya (Cannabis sativa) Leaf Extract
Cannabinoid Profile	THC-Dominant
Terpenes	Super Lemon Haze / OG Kush Cannabis-Derived Terpenes (CDT)
Total Cannabinoids	3860 mg
Delivery	Sublingual tincture

Advanced Extraction Profile

The formulation information describes Uplift Plus as being produced using advanced hydrocarbon extraction.

Hydrocarbon extraction uses controlled hydrocarbon solvents to separate lipid-soluble plant compounds from botanical material.

For cannabinoid products, appropriate purification and quality-control procedures are essential to ensure:

• Consistent cannabinoid concentration
• Removal of unwanted extraction residues
• Reproducible formulation quality
• Controlled terpene composition

The relevant Certificate of Analysis (COA) should be consulted for batch-specific cannabinoid concentrations and testing information.

Dosage Details

Because Uplift Plus is a concentrated THC-dominant formulation, dosing should always follow the principle of low initial exposure and gradual titration under medical supervision.

Beginner Dose

1 drop under the tongue after dinner

Only when recommended by a medical practitioner.

Standard Dose

1–2 drops under the tongue

According to the prescribing practitioner’s instructions.

Maximum Dose

Up to 0.25 mL

or as directed by your physician.

Dose Adjustment

The supplied instructions recommend increasing by one drop every alternate day until the desired response is achieved.

Because of the product’s high cannabinoid concentration, dose increases should not be made independently without professional guidance.

Frequency

Once daily or as prescribed.

Recommended Timing

The supplied formulation recommends evening or post-work use for relaxation and night-time support.

Why “Start Low and Go Slow” Matters

THC response varies dramatically between individuals.

Factors influencing cannabinoid sensitivity include:

• Previous cannabis exposure
• Body composition
• Liver metabolism
• Age
• Medication use
• Food intake
• Individual CB1 receptor sensitivity
• Existing tolerance

A dose that feels mild to one person may produce substantial psychoactive effects in another.

With concentrated tinctures, even a small change in volume can meaningfully change cannabinoid exposure.

Safety & Precautions

Psychoactive Formulation

Uplift Plus is psychoactive because it is THC-dominant.

Possible effects may include:

• Altered perception
• Drowsiness
• Euphoria
• Reduced reaction time
• Impaired coordination
• Changes in attention
• Short-term memory impairment
• Anxiety or restlessness

Use only under the advice of a qualified medical practitioner.

Do Not Drive

Do not drive or operate machinery after consuming Uplift Plus.

THC can impair reaction time, judgment, coordination, and attention.

Avoid Alcohol

Do not combine Uplift Plus with alcohol unless specifically instructed by your healthcare professional.

Alcohol may intensify impairment and unpredictable psychoactive effects.

Caffeine and Stimulants

The supplied product guidance recommends avoiding excessive caffeine and stimulants because they may alter the subjective experience of cannabinoid use, particularly in individuals sensitive to anxiety or palpitations.

Medication Interactions

THC and other cannabinoids may interact with medicines metabolized through hepatic enzyme pathways, including CYP450 enzymes.

Individuals taking prescription medicines should consult their physician before using this product.

Pregnancy and Breastfeeding

THC-containing products should not be used during pregnancy or breastfeeding unless specifically directed by an appropriately qualified medical specialist.

Psychiatric Conditions

Individuals with a personal or family history of psychosis, schizophrenia, mania, or severe cannabis-associated anxiety should seek medical advice before using THC-containing products.

Lab Reports & Quality Documentation

Cannazo India provides access to documentation including:

Certificate of Analysis (COA)

A batch-specific COA can help verify cannabinoid concentration and product quality.

AYUSH Licence

Provides regulatory documentation applicable to the product category and manufacturing framework.

GMP Certification

Good Manufacturing Practice certification supports controlled manufacturing and quality-management processes.

Customers should review the current batch-specific documentation before use.

Storage Instructions

Store Uplift Plus:

• In a cool, dry location
• Away from direct sunlight
• Away from excessive heat
• In its original packaging
• With the bottle securely closed

Keep away from children and pets.

Because this is a concentrated psychoactive product, secure storage is particularly important.

Frequently Asked Questions

What is Uplift Plus?

Uplift Plus is an extra-strength, THC-dominant full-spectrum Vijaya tincture containing 3860 mg total cannabinoids and infused with Super Lemon Haze and OG Kush cannabis-derived terpenes.

Is Uplift Plus psychoactive?

Yes. It is THC-dominant and can produce psychoactive effects.

Who should use Uplift Plus?

It is intended for experienced adult cannabinoid users only under the advice of a qualified medical practitioner.

How quickly does Uplift Plus work?

The listed onset is approximately 30–60 minutes when used sublingually, although individual responses vary.

How long can the effects last?

The listed duration is approximately 4–8 hours, with individual variation possible.

Can I drive after taking Uplift Plus?

No. Driving and operating machinery should be avoided after THC consumption.

Can Uplift Plus treat addiction?

It should not be considered or marketed as a de-addiction treatment. Individuals receiving treatment for alcohol, nicotine, or substance-use disorders should consult their healthcare professional before using a THC-containing product.

Can Uplift Plus treat depression or insomnia?

It should not be promoted as a treatment for depression or insomnia. Individuals with persistent mood or sleep problems should seek appropriate medical evaluation.

Why Choose Cannazo India Uplift Plus?

Cannazo India Uplift Plus combines a high-concentration THC-dominant full-spectrum Vijaya extract with Super Lemon Haze and OG Kush cannabis-derived terpenes in a concentrated sublingual format.

Its standardized cannabinoid profile, controlled dosing format, and supporting COA, AYUSH, and GMP documentation make it suitable for adults who have been specifically advised by a qualified medical practitioner to use a concentrated cannabinoid formulation.

The product’s principal distinction is its high cannabinoid concentration and full-spectrum phytochemical profile, rather than an isolated cannabinoid approach.

Because THC produces psychoactive effects, Uplift Plus should be approached as a medically supervised cannabinoid formulation rather than a conventional wellness supplement.

Medical Disclaimer

Uplift Plus is a THC-dominant, psychoactive cannabinoid formulation. It is not intended to diagnose, treat, cure, or prevent depression, anxiety disorders, insomnia, addiction, cancer, Parkinson’s disease, or any other medical condition. Any use for a medical condition should be undertaken only under the supervision of a qualified medical practitioner. Do not drive or operate machinery after use. Individual responses vary depending on dose, metabolism, tolerance, medications, and other physiological factors.